4 structures-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "https:" "https:" "Univ" positions at Institute of Physical Chemistry, Polish Academy of Sciences
-
shares key structural features with the active compound in Nirmatrelvir/Paxlovid, a widely used antiviral drug for the treatment of SARS-CoV-2 (Nature Chem Biol, 2021). Under this call, one doctoral
-
medicine. Among Prof. Drąg’s most prominent achievements is the development of a UAA-based inhibitor that shares key structural features with the active compound in Nirmatrelvir/Paxlovid, a widely used
-
(>100) with diverse structures and the evaluation of their catalytic performance in both processes (>1000 substrate–catalyst–conditions combinations). The resulting experimental dataset on catalyst
-
for analyzing the heterogeneity of microbiota and inferring activities of biological pathways. The Institute provides an international and interdisciplinary research environment. Details about the project: https